This trial will evaluate the safety, effectiveness and bioavailability of a standardized Green Tea Catechin formulation given over 24 months to men with low- to intermediate-grade prostate managed on active surveillance.
1 Primary · 6 Secondary · Reporting Duration: 24 months
Experimental Treatment
Non-Treatment Group
135 Total Participants · 2 Treatment Groups
Primary Treatment: Sunphenon · Has Placebo Group · Phase 2
Age 18+ · Male Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: